We are live on
!
Find out more
OCM
Ovata Capital Management Portfolio holdings
AUM
$715M
1-Year Est. Return
19.57%
This Fund
S&P 500
This Quarter
Est. Return
+12.09%
1 Year Est. Return
+19.57%
3 Year Est. Return
+68.09%
5 Year Est. Return
+54.93%
10 Year Est. Return
–
AUM
$135M
AUM Growth
–
Cap. Flow
+$128M
Cap. Flow
% of AUM
94.82%
Top 10 Holdings %
Top 10 Hldgs %
75.69%
Holding
32
New
31
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Takeda Pharmaceutical
TAK
|
+$16.8M |
| 2 |
Qfin Holdings
QFIN
|
+$9.05M |
| 3 |
NFH
New Frontier Health Corporation Ordinary Shares
NFH
|
+$8.17M |
| 4 |
Sony
SONY
|
+$6.57M |
| 5 |
NXP Semiconductors
NXPI
|
+$6.04M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.09% |
| 2 | Financials | 16.74% |
| 3 | Healthcare | 13.04% |
| 4 | Consumer Discretionary | 10.16% |
| 5 | Consumer Staples | 7.73% |
Similar funds
BFO
LFA
CFGSD
AIM
CFO
ECM
GEA
NI
Ovata Capital Management's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Ovata Capital Management, which disclosed 32 positions worth $135M. Its ten largest holdings account for 76% of the portfolio.
Its largest position is Takeda Pharmaceutical: 879,800 shares worth $17.6M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, followed by Financials and Healthcare.
- Ovata Capital Management's largest Q4 2019 buy was Takeda Pharmaceutical: 879,800 shares worth $17.6M.
- Ovata Capital Management's ten largest holdings make up 76% of its $135M portfolio in Q4 2019.
- Ovata Capital Management disclosed 32 positions in Q4 2019, its first 13F filing on record.
Based on Ovata Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.